The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, J.
Right arrow Articles by Rubin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, J.
Right arrow Articles by Rubin, B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
The Journal of Immunology, 2000, 164: 2084-2091.
Copyright © 2000 by The American Association of Immunologists

Involvement of Cytosolic Phospholipase A2 and Secretory Phospholipase A2 in Arachidonic Acid Release from Human Neutrophils1

John Marshall*, Eric Krump2,{ddagger}, Thomas Lindsay*, Gregory Downey{dagger}, David A. Ford§, Peihong Zhu*, Paul Walker* and Barry Rubin3,*

Divisions of * Vascular Surgery and {dagger} Respiratory Diseases, Max Bell Research Center, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; {ddagger} Division of Cell Biology, Sick Children’s Hospital, Toronto, Ontario, Canada; and § Department of Biochemistry and Molecular Biology, St. Louis University Health Sciences Center, St. Louis, MO 63104

The purpose of this study was to define the role of secretory phospholipase A2 (sPLA2), calcium-independent PLA2, and cytosolic PLA2 (cPLA2) in arachidonic acid (AA) release from fMLP-stimulated human neutrophils. While fMLP induced the release of extracellular sPLA2 activity and AA, 70% of sPLA2 activity remained associated with the cell. Treatment with the cell-impermeable sPLA2 inhibitors DTT or LY311-727, or the anti-sPLA2 Ab 3F10 all inactivated extracellular sPLA2 activity, but had minimal effect on neutrophil AA mass release. In contrast, coincubation of streptolysin-O toxin-permeabilized neutrophils with DTT, LY311-727, or 3F10 all decreased [3H8]AA release from [3H8]AA-labeled, fMLP-stimulated cells. Exposure to fMLP resulted in a decrease in the electrophoretic mobility of cPLA2, a finding consistent with cPLA2 phosphorylation, and stimulated the translocation of cPLA2 from cytosolic to microsomal and nuclear compartments. The role of cPLA2 was further evaluated with the cPLA2 inhibitor methyl arachidonyl fluorophosphonate, which attenuated cPLA2 activity in vitro and decreased fMLP-stimulated AA mass release by intact neutrophils, but had no effect on neutrophil sPLA2 activity. Inhibition of calcium-independent PLA2 with haloenol lactone suicide substrate had no effect on neutrophil cPLA2 activity or AA mass release. These results indicate a role for cPLA2 and an intracellular or cell-associated sPLA2 in the release of AA from fMLP-stimulated human neutrophils.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
S. Brechard and E. J. Tschirhart
Regulation of superoxide production in neutrophils: role of calcium influx
J. Leukoc. Biol., November 1, 2008; 84(5): 1223 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Ruiperez, J. Casas, M. A. Balboa, and J. Balsinde
Group V Phospholipase A2-Derived Lysophosphatidylcholine Mediates Cyclooxygenase-2 Induction in Lipopolysaccharide-Stimulated Macrophages
J. Immunol., July 1, 2007; 179(1): 631 - 638.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. C. Frasch, K. Zemski-Berry, R. C. Murphy, N. Borregaard, P. M. Henson, and D. L. Bratton
Lysophospholipids of Different Classes Mobilize Neutrophil Secretory Vesicles and Induce Redundant Signaling through G2A
J. Immunol., May 15, 2007; 178(10): 6540 - 6548.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
I. Pessach, Z. Shmelzer, T. L. Leto, M. C. Dinauer, and R. Levy
The C-terminal flavin domain of gp91phox bound to plasma membranes of granulocyte-like X-CGD PLB-985 cells is sufficient to anchor cytosolic oxidase components and support NADPH oxidase-associated diaphorase activity independent of cytosolic phospholipase A2 regulation
J. Leukoc. Biol., September 1, 2006; 80(3): 630 - 639.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Iizuka, T. Yokomizo, K. Terawaki, M. Komine, K. Tamaki, and T. Shimizu
Characterization of a Mouse Second Leukotriene B4 Receptor, mBLT2: BLT2-DEPENDENT ERK ACTIVATION AND CELL MIGRATION OF PRIMARY MOUSE KERATINOCYTES
J. Biol. Chem., July 1, 2005; 280(26): 24816 - 24823.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. B. Rubin, G. P. Downey, A. Koh, N. Degousee, F. Ghomashchi, L. Nallan, E. Stefanski, D. W. Harkin, C. Sun, B. P. Smart, et al.
Cytosolic Phospholipase A2-{alpha} Is Necessary for Platelet-activating Factor Biosynthesis, Efficient Neutrophil-mediated Bacterial Killing, and the Innate Immune Response to Pulmonary Infection: cPLA2-{alpha} DOES NOT REGULATE NEUTROPHIL NADPH OXIDASE ACTIVITY
J. Biol. Chem., March 4, 2005; 280(9): 7519 - 7529.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
H. W.M Niessen, P. A.J Krijnen, C. A Visser, C. J.L.M Meijer, and C Erik Hack
Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?
Cardiovasc Res, October 15, 2003; 60(1): 68 - 77.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. K.M. Wong, A. I. Pettit, P. A. Quinn, S. C. Jennings, J. E. Davies, and L. L. Ng
Advanced Glycation End Products Stimulate an Enhanced Neutrophil Respiratory Burst Mediated Through the Activation of Cytosolic Phospholipase A2 and Generation of Arachidonic Acid
Circulation, October 14, 2003; 108(15): 1858 - 1864.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-S. Bae, J. C. Park, R. He, R. D. Ye, J.-Y. Kwak, P.-G. Suh, and S. Ho Ryu
Differential Signaling of Formyl Peptide Receptor-Like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or Lipoxin A4 in Human Neutrophils
Mol. Pharmacol., September 1, 2003; 64(3): 721 - 730.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
Z. Shmelzer, N. Haddad, E. Admon, I. Pessach, T. L. Leto, Z. Eitan-Hazan, M. Hershfinkel, and R. Levy
Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes
J. Cell Biol., August 18, 2003; 162(4): 683 - 692.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. J. Kim, K. P. Kim, S. K. Han, N. M. Munoz, X. Zhu, H. Sano, A. R. Leff, and W. Cho
Group V Phospholipase A2 Induces Leukotriene Biosynthesis in Human Neutrophils through the Activation of Group IVA Phospholipase A2
J. Biol. Chem., September 20, 2002; 277(39): 36479 - 36488.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Degousee, F. Ghomashchi, E. Stefanski, A. Singer, B. P. Smart, N. Borregaard, R. Reithmeier, T. F. Lindsay, C. Lichtenberger, W. Reinisch, et al.
Groups IV, V, and X Phospholipases A2s in Human Neutrophils. ROLE IN EICOSANOID PRODUCTION AND GRAM-NEGATIVE BACTERIAL PHOSPHOLIPID HYDROLYSIS
J. Biol. Chem., February 8, 2002; 277(7): 5061 - 5073.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Teixeira, C. Bernard, E. Ferrary, and D. Butlen
Purine and pyrimidine nucleotide-sensitive phospholipase A2 in ampulla from frog semicircular canal
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R519 - R526.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.